Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)

Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer

This cross-sectional study of pathophysiology will bring additional informations on body composition of patients treated by adjuvant hormonal therapy for breast cancer. This is a complementary study of Metaca study (AU882).

Inclusion Criteria:

• postmenopausal women
• patients requiring hormonal treatment
• WHO performance status 0-2
• patients initially included in MetaCa (AU882) protocol
• Affiliation to a social security scheme (or be the beneficiary of such a plan)
• patients who signed the informed consent form

Exclusion Criteria:

• patients witg relapse, with metastases or other cancer
• concurrent treatment with a drug test, or participation in a clinical trial within < 30 days
• patients carrying an electronic medical device (eg pacemaker)
• patients who refused to sign the consent form